SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
Allogene Therapeutics at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Allogene Therapeutics brings 3 presentations to SITC 2026 in Phoenix. Its program centres on off-the-shelf CAR T cells made from donor cells and how they could widen patient access. A concrete highlight is clinical experience with a donor-derived CAR T treatment for kidney cancer in the TRAVERSE study.
| Organization | SITC 2026 Attendance |
|---|---|
Allogene Therapeutics South San Francisco, CA | |
Clinical-stage company developing allogeneic, off-the-shelf CAR T cell therapies. | Talk Thu Nov 5 9:05am–9:15am Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Talk Fri Nov 6 4:25pm–4:40pm |
Find decision makers at Allogene Therapeutics
Tell us what you sell and we’ll find the people at Allogene Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction